Essa Pharma

Essa Pharma company information, Employees & Contact Information

Explore related pages

Essa Pharma email format Essa Pharma management contacts

Related company profiles:

ESSA is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. ESSA’s lead clinical candidate, EPI-7386, represents a new approach to disrupting androgen receptor signaling pathway, the primary driver of prostate cancer growth.

Company Details

Employees
23
Address
999 West Broadway,
Phone
(832) 831-5958
Email
in****@****rma.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
essapharma.com
HQ
Vancouver , British Columbia
Competitors
VERALOX Therapeutics, Z-Alpha Therapeutics, Garuda Therapeutics, CARsgen Therapeutics, Heritage Pharmaceuticals, Eupraxia Pharmaceuticals Inc., XenoTherapeutics, Abcuro, Inc, Iterion Therapeutics, Gandeeva Therapeutics.
Looking for a particular Essa Pharma employee's phone or email?

Essa Pharma Questions

News

Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025 - Yahoo Finance

Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025 Yahoo Finance

ESSA Pharma to be Acquired by XenoTherapeutics, Backed by XOMA Royalty - citybiz

ESSA Pharma to be Acquired by XenoTherapeutics, Backed by XOMA Royalty citybiz

ESSA Pharma Plans $1.91 Per Share Distribution Before XenoTherapeutics Merger - Court Hearing Set - Stock Titan

ESSA Pharma Plans $1.91 Per Share Distribution Before XenoTherapeutics Merger - Court Hearing Set Stock Titan

ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order - Yahoo

ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order Yahoo

ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025 - Yahoo Finance

ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025 Yahoo Finance

Phase 2 trial of masofaniten plus enzalutamide in mCRPC has been terminated - Urology Times

Phase 2 trial of masofaniten plus enzalutamide in mCRPC has been terminated Urology Times

ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer - Stock Titan

ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer Stock Titan

Up to $6.7M CVR: ESSA Acquired by XenoTherapeutics for $0.1242/Share; Nasdaq delisting expected - Stock Titan

Up to $6.7M CVR: ESSA Acquired by XenoTherapeutics for $0.1242/Share; Nasdaq delisting expected Stock Titan

ESSA Pharma halts Phase II study of masofaniten in prostate cancer treatment - Clinical Trials Arena

ESSA Pharma halts Phase II study of masofaniten in prostate cancer treatment Clinical Trials Arena

Caris Life Sciences and ESSA Pharma Announce Liquid Biopsy Profiling Collaboration - PR Newswire

Caris Life Sciences and ESSA Pharma Announce Liquid Biopsy Profiling Collaboration PR Newswire

ESSA Pharma Enhances R&D Capabilities with Two New Key Hires - PR Newswire

ESSA Pharma Enhances R&D Capabilities with Two New Key Hires PR Newswire

ESSA Pharma’s Speculative Buy Potential: Masofaniten Promise For Prostate Cancer (EPIX) - Seeking Alpha

ESSA Pharma’s Speculative Buy Potential: Masofaniten Promise For Prostate Cancer (EPIX) Seeking Alpha

ESSA Pharma Clarifies Share Trading Period Details - TipRanks

ESSA Pharma Clarifies Share Trading Period Details TipRanks

ESSA Pharma Inc. Announces Share Consolidation - PR Newswire

ESSA Pharma Inc. Announces Share Consolidation PR Newswire

ESSA Pharma Announces Overnight Marketed Equity Offering - PR Newswire

ESSA Pharma Announces Overnight Marketed Equity Offering PR Newswire

XenoTherapeutics to acquire ESSA Pharma in deal backed by XOMA Royalty - Canadian Lawyer Mag

XenoTherapeutics to acquire ESSA Pharma in deal backed by XOMA Royalty Canadian Lawyer Mag

ESSA Pharma Announces Overnight Marketed Equity Offering - PR Newswire

ESSA Pharma Announces Overnight Marketed Equity Offering PR Newswire

ESSA Pharma Inc (EPIX) Stock Crashed: How to Trade EPIX Stock CFDs? - Markets.com

ESSA Pharma Inc (EPIX) Stock Crashed: How to Trade EPIX Stock CFDs? Markets.com

Companies like Essa Pharma

Gandeeva Therapeutics logo - Similar company to Essa Pharma

Gandeeva Therapeutics

28
Eupraxia Pharmaceuticals Inc. logo - Similar company to Essa Pharma

Eupraxia Pharmaceuti...

44
Garuda Therapeutics logo - Similar company to Essa Pharma

Garuda Therapeutics

20
CARsgen Therapeutics logo - Similar company to Essa Pharma

Carsgen Therapeutics

98
Heritage Pharmaceuticals logo - Similar company to Essa Pharma

Heritage Pharmaceuti...

2
VERALOX Therapeutics logo - Similar company to Essa Pharma

Veralox Therapeutics

18
Z-Alpha Therapeutics logo - Similar company to Essa Pharma

Z-Alpha Therapeutics

19
XenoTherapeutics logo - Similar company to Essa Pharma

Xenotherapeutics

13
Iterion Therapeutics logo - Similar company to Essa Pharma

Iterion Therapeutics

16
Abcuro, Inc logo - Similar company to Essa Pharma

Abcuro, Inc

53

Top Essa Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant